Fin Trust Capital Advisors, LLC Nevro Corp Transaction History

Fin Trust Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$101.99 - $166.36 $10,606 - $17,301	-104 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $414 - $553	-3 Reduced 2.8%	104 $18,000
Q3 2020 Nov 10, 2020	BUY	$114.09 - $145.51 $8,899 - $11,349	78 Added 268.97%	107 $15,000
Q2 2020 Sep 11, 2020	BUY	$89.45 - $129.85 $2,594 - $3,765	29 New	29 $3,000
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $2,594 - $3,765	-29 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$76.41 - $117.54 $382 - $587	5 Added 20.83%	29 $3,000
Q3 2019 Oct 29, 2019	BUY	$61.52 - $91.1 $1,476 - $2,186	24 New	24 $2,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.